Related Experiment Videos
Certainly no ARFterthought: oncogenic cooperation in ARF induction a key step in tumor suppression
1Laulenberg Center for General and Tumor Immunology, The Hebrew University Hodossoh Medical School, Jerusalem 91120 Israel. haupt@md.huii.ac.il
Cell Cycle (Georgetown, Tex.)
|April 16, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Apoptotic cell death in disease-Current understanding of the NCCD 2023.
Cell death and differentiation·2023
Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes.
Journal for immunotherapy of cancer·2022
SLC7A11 Is a Superior Determinant of APR-246 (Eprenetapopt) Response than TP53 Mutation Status.
Molecular cancer therapeutics·2021
Upregulation of ITM2A by p53 activation modulates p53 function through physical interaction.
Cell cycle (Georgetown, Tex.)·2026
The hormetic landscape: from evolutionary origination to mechanistic pathways in therapeutics.
Cell cycle (Georgetown, Tex.)·2026
The effect of energy metabolism on embryonic development and endometrial receptivity in patients with repeated implantation failure.
Cell cycle (Georgetown, Tex.)·2026
The role of IL-37 in inflammatory bowel disease and colitis-associated colorectal cancer.
Cell cycle (Georgetown, Tex.)·2026
Exploratory multi-omics links CCL2/TIMP1 axis to immunosuppressive TME in glioblastoma.
Cell cycle (Georgetown, Tex.)·2026
YTHDC1 Orchestrates Glucose and Glutamate Rewiring to Overcome Lethal Metabolic Stress in Triple-Negative Breast Cancer.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Natural Product Toosendanin Suppresses the Malignant Development of Skin Melanoma by Targeting BNC2 for Degradation.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Cardio-renal protection of MRAs in kidney-transplanted diabetic patients.
Pharmacological research·2026
Substrate-Derived Peptides for Selective Covalent Inhibition of Protein Tyrosine Kinases.
ACS chemical biology·2026